Dr. WhiteFeather Hunter joins cMAS as a post-doctoral fellow
We are really excited to announce that Dr. WhiteFeather Hunter will be joining cMAS and School of Interactive Arts and Technology as a SSHRC Post-Doctoral fellow this May.
Congratulations Dr. Hunter, we are really looking forward to working with you!
Dr. WhiteFeather Hunter is an internationally recognized Canadian artist and researcher, recently awarded a SSHRC Postdoctoral Research Fellowship. WhiteFeather holds a PhD in Biological Art through SymbioticA, The University of Western Australia, and an MFA in Fibres and Material Practices from Concordia University. Her doctoral thesis, “The Witch in the Lab Coat” was a TechnoFeminist negotiation of science biocultures by using ‘taboo’ materials such as menstrual fluid in tissue engineering protocols and producing DIY lab hardware; this included witchcraft as performed resistance to medicalized control over women’s bodies. Recent projects include Sentient Clit—The Pussification of Biotech, an exploration of 3D-bioprinting clitorises embedded with her menstrual stem cells differentiated to neuronal types, in order to produce a synthetic organ that responds to stimuli. The project was awarded an Ars Electronica 2024 S+T+ARTS Prize jury nomination. WhiteFeather exhibits internationally, recently (solo) at the Museum of Witchcraft and Magic (Cornwall, UK), MKII (London, UK), Plexus Projects (NYC, US), Ectopia Lab (Lisbon, PT), and SomoS Arts (Berlin, DE). She is hosted at prestigious international biolabs, such as the Gulbenkian Institute of Molecular Medicine, uLisboa, University of Ottawa Heart Institute, and DZNE German Center for Neurodegenerative Diseases. WhiteFeather presents at high profile festivals, conferences, and residencies across the globe, most recently delivering a keynote address on feminist transdisciplinary research-creation for the Future Humanities Institute, University College Cork (IE). She is published in peer-reviewed journals and books in Australia, UK, Greece, France, Denmark, Canada, and USA, with forthcoming publications in Austria, Australia, and the UK.